You are here

A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Wichita, Kansas, 67207 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Alzheimer's Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
55-85 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Probable Alzheimer's disease

- Mini Mental State Examination score 18-26 inclusive

- Aged 55-85

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Dementia other than Alzheimer's disease

- Clinically significant cardiovascular disease in the past 6 months prior to screening

- Creatinine clearance

NCT01028911
Pfizer
Terminated
A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Alzheimer's Disease
NCT00499200
All Genders
60+
Years
Uppsala,
Alzheimer's Disease
NCT00151333
All Genders
50+
Years
Multiple Sites
Alzheimer's Disease
NCT01227564
All Genders
50+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now